Viewing Study NCT00123851


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-06-26 @ 4:39 PM
Study NCT ID: NCT00123851
Status: COMPLETED
Last Update Posted: 2009-04-28
First Post: 2005-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer
Sponsor: Dana-Farber Cancer Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 02-269
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None INDUSTRY View
None INDUSTRY View
None INDUSTRY View
None OTHER View
None OTHER View